LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Dental fillings 2026–2027: IHS amalgam phase-out questions
IHS is ending mercury-containing dental amalgam use by 2027. If you’re offered a filling during 2026–2027—or you’re thinking about replacing an existing “silver” filling—these questions can help you make an informed choice about materials, risks, benefits, and dental need.
FDA Updates OTC Alli (Orlistat) Label for Rare Kidney Injury Warning
On June 10, 2026, the FDA approved label updates for OTC alli (orlistat) 60 mg that add clearer warnings about rare but serious kidney risks, including kidney stones. If you have a history of kidney disease or kidney stones, the label advises asking…
How to Read CDC Wastewater SARS‑CoV‑2 Data and What Families Should Do Next
CDC’s national wastewater dashboard updates every Friday. Learn what “wastewater viral activity” means, what it can’t tell you about individuals, and how families can use the signal to plan everyday prevention and keep vaccines up to date.
FDA Recall for a DBS Neurostimulator: How to Check Your Device
Seeing an FDA recall record for an implanted deep brain stimulation (DBS) neurostimulator can be alarming. Here’s what the specific FDA record for Medtronic Kinetra model 7428 describes, how to check your device identifiers, and when symptom changes should trigger urgent care.
Pregnant in 2026: Matching ACOG vs CDC timing for RSV and COVID-19
ACOG’s pregnancy vaccine schedule and CDC’s vaccine-table view can look mismatched at first glance—especially for COVID-19. Here’s how to use ACOG for the “what to plan,” then use CDC’s dedicated pregnancy pages to confirm the timing logic for RSV (Abrysvo) and COVID-19.
Check FDA’s AI-Enabled Device List for Marketing Authorization
FDA updated its AI-Enabled Medical Devices list on June 16, 2026. Here’s how patients, caregivers, and clinician-adjacent readers can check whether an AI-enabled medical device is FDA-authorized—and what the list and linked FDA entries do (and don’t) tell you.
Blood tests for colon cancer screening: what “not preferred” really means
In 2026, the American Cancer Society labeled blood-based colorectal cancer screening tests as “not preferred.” Here’s what that means for everyday decisions—what to ask if a clinic offers a blood test, and why a positive result still requires timely colonoscopy follow-up.
CASTL Trial & Lung Cancer Screening: Quit-Smoking Support in 2026
A July 8, 2026 CASTL trial tests how to deliver smoking-cessation components during lung cancer screening visits—using cost-and-effectiveness “value” to find approaches that are practical to scale in real-world programs.
Whole Milk Is Returning to Some School Lunches: What Families Should Know
A USDA final rule effective June 8, 2026 expands which “fluid milk” options participating schools and child care sites can offer. If you’re seeing whole milk or 2% milk on your child’s menu in summer 2026, here’s how to understand the change—and what…
Measles Exposure: Act Fast—MMR in 72 Hours, Immune Globulin in 6 Days
After a measles exposure at daycare/school, timing matters. MMR works best within 72 hours of the first exposure. Immune globulin may be an option within 6 days for people who can’t safely get MMR—so call a clinician and follow local public health instructions…
Medicare’s $50 GLP-1 Bridge: Who Qualifies and How to Get Treated
Medicare’s time-limited “GLP-1 Bridge” starts July 1, 2026. If you’re enrolled in an eligible Medicare Part D plan type and meet CMS’s age/BMI and health-condition criteria, your clinician can request prior authorization for certain FDA-approved GLP-1 weight-loss drugs—with a $50 copay per month…
What Medicaid “Community Engagement” Means for Coverage Starting in 2027
CMS’s June 1, 2026 interim final rule creates a Medicaid eligibility condition for certain non-pregnant adults to meet an 80-hours-per-month “community engagement” standard (or another qualifying basis). The rule also requires states to verify compliance and give enrollees a 30-calendar-day response window if…